[{"Assets_0_Q1_USD":2946703000.0,"CommonStockSharesOutstanding_0_Q1_shares":248890834.0,"EarningsPerShareBasic_1_Q1_USD":1.01,"EarningsPerShareDiluted_1_Q1_USD":0.99,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":265692000.0,"NetIncomeLoss_1_Q1_USD":247756000.0,"StockholdersEquity_0_Q1_USD":1500008000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":248700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":246024000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170428"}]